BEXAROTENE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where BEXAROTENE was used for Neoplasm malignant.
Most Reported Side Effects for BEXAROTENE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 67 | 8.8% | 13 | 9 |
| Hypothyroidism | 65 | 8.6% | 14 | 24 |
| Death | 53 | 7.0% | 51 | 3 |
| Hypertriglyceridaemia | 44 | 5.8% | 14 | 15 |
| Off label use | 32 | 4.2% | 6 | 7 |
| Disease progression | 28 | 3.7% | 14 | 13 |
| Blood cholesterol increased | 27 | 3.6% | 0 | 6 |
| Malignant neoplasm progression | 26 | 3.4% | 17 | 5 |
| Pruritus | 24 | 3.2% | 0 | 2 |
| Nausea | 22 | 2.9% | 1 | 1 |
| Blood triglycerides increased | 20 | 2.6% | 0 | 2 |
| Fatigue | 20 | 2.6% | 0 | 0 |
| Dyslipidaemia | 19 | 2.5% | 3 | 6 |
| Oedema peripheral | 18 | 2.4% | 0 | 13 |
| Headache | 17 | 2.2% | 0 | 0 |
Other Indications for BEXAROTENE
Cutaneous t-cell lymphoma (266)
Mycosis fungoides (125)
Product used for unknown indication (90)
T-cell lymphoma (24)
Lymphoma (14)
Cutaneous t-cell lymphoma stage iv (9)
Peripheral t-cell lymphoma unspecified (8)
Cutaneous lymphoma (7)
Adult t-cell lymphoma/leukaemia (5)
Anaplastic large cell lymphoma t- and null-cell types (5)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)